export const sl202602html = `
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Glutathione and Nitrogen Metabolism SNP Summary</title>
    <style>
        body {
            font-family: Arial, Helvetica, sans-serif;
            line-height: 1.5;
            max-width: 900px;
            margin: 40px auto;
            color: #222;
        }
        p {
            margin: 0 0 1em 0;
        }
        .heading {
            font-weight: bold;
            margin-top: 1.5em;
        }
    </style>
</head>
<body>
<div><div><font size="5">CYP1A1 (Cytochrome P450 1A1)</font></div><div><br></div><div><p>CYP1A1 encodes a Phase I detoxification enzyme that oxidizes environmental pollutants, polycyclic aromatic hydrocarbons and endogenous substrates including estrogen metabolites. During catalytic cycling, electrons are transferred from NADPH to oxygen, generating reactive intermediates and reactive oxygen species as byproducts. CYP1A1 therefore increases oxidative input pressure during detox activation.</p><p>SNP: rs1048943&nbsp;<span>&nbsp;</span>Change: A &gt; G&nbsp;<span>&nbsp;</span>Risk allele: G&nbsp;<span>&nbsp;</span>(Ile462Val)</p><p>This is a missense structural variant causing an isoleucine to valine substitution at position 462 near the heme-binding region. It alters catalytic behavior rather than transcription.</p><p>Functional Effect</p><p></p><ul><li>Increased catalytic activity once induced</li><li>Greater ROS generation per unit activity</li><li>Faster formation of reactive epoxides and quinones</li><li>Higher downstream glutathione and conjugation demand</li></ul><p></p><p>SNP: rs4646903&nbsp;<span>&nbsp;</span>Change: T &gt; C&nbsp;<span>&nbsp;</span>Risk allele: C</p><p>This is a regulatory variant in the 3′ noncoding region associated with increased inducibility and prolonged expression following AHR activation.</p><p>Functional Effect</p><p></p><ul><li>Higher responsiveness to AHR ligands</li><li>Prolonged CYP1A1 expression after exposure</li><li>Greater cumulative Phase I output over time</li><li>Increased pressure on downstream detox systems</li></ul><p></p><p>Normal Phase I State</p><p>Balanced induction → controlled ROS generation → adequate conjugation → stable redox tone.</p><p>Amplified Phase I State</p><p>↑ Induction or ↑ catalytic velocity → ↑ reactive intermediates → ↑ ROS → ↑ oxidative demand.</p></div><div><br></div><div>Pathways</div><div><ul><li>Phase I xenobiotic metabolism.</li><li>Estrogen metabolite oxidation.</li><li>Aryl hydrocarbon receptor AHR signaling.</li><li>Detox-redox cross-talk with glutathione systems.</li></ul></div><div><br></div><div>Nutrients &amp; Cofactors</div><div><ul><li>Riboflavin and niacin for NADPH generation.</li><li>Magnesium for ATP-dependent processes.</li><li>Glutathione for reactive intermediate buffering.</li><li>Polyphenols EGCG, quercetin to moderate excessive CYP induction.</li></ul></div><div><br></div><div>Hindered By</div><div><ul><li>High pollutant load.</li><li>Smoking and PAH exposure.</li><li>Low glutathione availability.</li><li>Mold toxins and chronic inflammatory states.</li></ul></div><div><br></div><div>Peptides</div><div><ul><li>MOTS-c: improves metabolic flexibility and reduces oxidative spillover.</li><li>GHK-Cu: supports antioxidant gene expression and redox stabilization.</li><li>See more in this month’s workbook</li></ul></div><div><br></div><div><font size="5">CYB5R3 (Cytochrome b5 Reductase)</font></div><div><br></div><div><p>CYB5R3 encodes a flavoprotein that transfers electrons from NADH to cytochrome b5 and other substrates. It supports coenzyme Q reduction, methemoglobin reduction and overall electron stability. Regulatory variation can subtly reduce redox reserve under metabolic load.</p><p>SNP: rs8190955&nbsp;<span>&nbsp;</span>Change: G &gt; A&nbsp;<span>&nbsp;</span>Risk allele: A</p><p>Likely intronic regulatory variant influencing transcription efficiency or mRNA processing.</p><p>SNP: rs2978663&nbsp;<span>&nbsp;</span>Change: G &gt; A&nbsp;<span>&nbsp;</span>Risk allele: A</p><p>Intronic regulatory variant most consistent with transcriptional modulation or altered splicing efficiency.</p><p>SNP: rs2551715&nbsp;<span>&nbsp;</span>Change: C &gt; T&nbsp;<span>&nbsp;</span>Risk allele: T</p><p>Intronic regulatory variant associated with conditional cardiometabolic modulation depending on diet and BMI context.</p><p>SNP: rs2911678&nbsp;<span>&nbsp;</span>Change: T &gt; A&nbsp;<span>&nbsp;</span>Risk allele: A</p><p>Intronic regulatory variant influencing expression efficiency under metabolic stress.</p><p>SNP: rs3757918&nbsp;<span>&nbsp;</span>Change: T &gt; C&nbsp;<span>&nbsp;</span>Risk allele: C</p><p>Intronic regulatory variant within the same studied cluster, likely altering regulatory architecture and expression amplitude.</p><p><br></p><p>Unified Functional Impact</p><p></p><ul><li>Reduced ability to regenerate reduced CoQ efficiently</li><li>Greater mitochondrial ROS propagation under high metabolic flux</li><li>Increased oxidative sensitivity during inflammation</li><li>Amplified endothelial oxidative tone</li><li>Higher susceptibility to cardiometabolic strain when diet quality is low</li></ul><p></p><p><br></p><p>Normal Electron Handling State</p><p>Efficient CoQ reduction → stable electron flow → limited ROS propagation.</p><p>Reduced Reserve State</p><p>↓ CYB5R3 output under load → ↑ electron drift → ↑ mitochondrial ROS → ↑ endothelial oxidative stress.</p></div><div><br></div><div>Pathways</div><div><ul><li>Methemoglobin reduction cycle.</li><li>Fatty acid desaturation.</li><li>Cholesterol redox regulation.</li><li>Cross-talk with mitochondrial and NOX-derived ROS.</li></ul></div><div><br></div><div>Nutrients &amp; Cofactors</div><div><ul><li>Riboflavin B2 for FAD-dependent activity.</li><li>Niacin for NADH supply.</li><li>Iron balance for hemoglobin stability.</li><li>Selenium and glutathione for downstream ROS buffering.</li></ul></div><div><br></div><div>Hindered By</div><div><ul><li>Hypoxia.</li><li>Mold toxins and mitochondrial inhibitors.</li><li>Iron overload.</li><li>Chronic inflammation increasing redox load.</li></ul></div><div><br></div><div>Peptides</div><div><ul><li>SS-31: improves mitochondrial electron efficiency, reducing spillover.</li><li>Carnosine: buffers carbonyl stress from lipid peroxidation.</li><li>GHK-Cu: supports redox-regulated gene expression.</li></ul></div><div><br></div><div><font size="5">CYBA (p22phox, NADPH Oxidase Subunit)</font></div><div><br></div><div><div>CYBA encodes p22phox, a structural subunit required for NADPH oxidase assembly. NADPH oxidase transfers electrons from NADPH to oxygen, generating superoxide intentionally for immune and vascular signaling. Variants tune NOX-derived superoxide magnitude.</div><div><br></div><div>SNP: rs4673 &nbsp;Change: C &gt; T &nbsp;Risk allele: context-dependent</div><div>Missense variant often referred to as C242T or H72Y. Alters p22phox structure and can shift NOX complex efficiency.</div><div><br></div><div>Primary Effect</div><div><ul><li>Alters NOX complex efficiency</li><li>Trigger-amplified under immune, vascular or metabolic load</li><li>May increase or decrease stimulus-driven superoxide depending on haplotype context</li></ul></div><div><br></div><div>SNP: rs9932581 &nbsp;Change: G &gt; A &nbsp;Risk allele: G</div><div>Promoter variant located approximately −930 bp from transcription start site.</div><div><br></div><div>Primary Effect</div><div><ul><li>Higher transcriptional activity for G allele</li><li>Higher baseline p22phox availability</li><li>Greater NOX readiness under inflammatory, angiotensin II and glycemic stress</li></ul></div><div><br></div><div>SNP: rs1049254 &nbsp;Change: T &gt; C &nbsp;Risk allele: context-dependent</div><div>Often part of rs4673–rs1049254–rs1049255 haplotype associated with altered ROS magnitude.</div><div><br></div><div>SNP: rs1049255 &nbsp;Change: G &gt; A &nbsp;Risk allele: context-dependent</div><div>3′ UTR variant influencing post-transcriptional regulation within haplotype clusters.</div><div><br></div><div>Unified Functional Impact</div><div><ul><li>Shifted NOX-derived superoxide tone</li><li>Altered nitric oxide bioavailability via superoxide–NO interaction</li><li>Increased peroxynitrite pressure under oxidative conditions</li><li>Amplified redox-sensitive inflammatory signaling</li><li>Higher downstream antioxidant demand</li></ul></div><div><br></div><div>Normal NOX State</div><div>Controlled superoxide signaling → preserved nitric oxide → transient ROS bursts → vascular stability.</div><div><br></div><div>Amplified NOX State</div><div>↑ Superoxide → ↓ NO bioavailability → ↑ peroxynitrite → ↑ endothelial dysfunction and inflammatory amplification.</div></div><div><br></div><div>Pathways</div><div><ul><li>RAAS-mediated oxidative signaling.</li><li>TLR4-endotoxin activation.</li><li>PKC activation in hyperglycemia.</li><li>Vascular redox signaling and NO quenching.</li></ul></div><div><br></div><div>Nutrients &amp; Cofactors</div><div><ul><li>Magnesium for vascular stability.</li><li>Selenium for glutathione peroxidase support.</li><li>Polyphenols green tea, quercetin, resveratrol for NOX modulation.</li><li>Omega-3 fatty acids for membrane resilience.</li></ul></div><div><br></div><div>Hindered By</div><div><ul><li>Chronic inflammation TNF-α, IL-6.</li><li>Angiotensin II excess.</li><li>Hyperglycemia and insulin resistance.</li><li>Smoking and pollution exposure.</li></ul></div><div><br></div><div>Peptides</div><div>SS-31: lowers upstream mitochondrial ROS that can activate NOX.</div><div>KPV: reduces cytokine-driven NOX activation.</div><div>MOTS-c: improves insulin sensitivity reducing PKC-mediated NOX activation.</div><div>GHK-Cu: modulates inflammatory signaling and endothelial repair.</div></div>
</body>
</html>
`